Andrew M. Brophy - 31 Dec 2023 Form 4 Insider Report for HEALTHCARE SERVICES GROUP INC (HCSG)

Role
Principal Accounting Officer
Signature
/s/ Andrew M. Brophy
Issuer symbol
HCSG
Transactions as of
31 Dec 2023
Net transactions value
+$10,733
Form type
4
Filing time
08 Jan 2024, 17:07:15 UTC
Previous filing
28 Feb 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCSG Common Stock Award $0 +4,826 +132% $0.000000 8,470 03 Jan 2024 Direct F1
transaction HCSG Common Stock Options Exercise $0 +23 +0.27% $0.000000 8,493 04 Jan 2024 Direct
transaction HCSG Common Stock Options Exercise $0 +123 +1.4% $0.000000 8,616 03 Jan 2024 Direct
transaction HCSG Common Stock Options Exercise $0 +141 +1.6% $0.000000 8,757 04 Jan 2024 Direct
transaction HCSG Common Stock Options Exercise $0 +552 +6.3% $0.000000 9,309 04 Jan 2024 Direct
transaction HCSG Common Stock Tax liability $0 -204 -2.2% $0.000000 9,105 03 Jan 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCSG Phantom Stock Award $10,733 +1,035 +57% $10.37 2,854 31 Dec 2023 Common Stock 1,035 Direct F3, F4, F5
transaction HCSG Restricted Stock Units Options Exercise $0 -23 -100% $0.000000* 0 04 Jan 2024 Common Stock 23 Direct F3, F6
transaction HCSG Restricted Stock Units Options Exercise $0 -123 -50% $0.000000 122 03 Jan 2024 Common Stock 123 Direct F3, F7
transaction HCSG Restricted Stock Units Options Exercise $0 -141 -33% $0.000000 282 04 Jan 2024 Common Stock 141 Direct F3, F8
transaction HCSG Restricted Stock Units Options Exercise $0 -552 -25% $0.000000 1,658 04 Jan 2024 Common Stock 552 Direct F3, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2024 grant date.
F2 Amount includes 8,470 unvested restricted stock units
F3 Shares issued at the conversion rate of 1-for-1.
F4 Shares of Phantom Stock are payable in-kind following termination of the Reporting Person's employment with Issuer.
F5 Acquired pursuant to an Issuer contribution under the Healthcare Services Group, Inc. Deferred Compensation Plan.
F6 Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2019 grant date.
F7 Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2020 grant date.
F8 Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2021 grant date.
F9 Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2022 grant date.